Liver cancer of 5cm is considered as small liver cancer. Currently, the preferred and most effective treatment for liver cancer is hepatectomy, and the 5-year survival rate after surgery is about 70%.
Hepatocellular carcinoma is the most common malignant tumor. Studies have shown that the causative factors of hepatocellular carcinoma include viral hepatitis, cirrhosis, aflatoxin and other chemical carcinogens.
Hepatocellular carcinoma with a diameter greater than 2 cm and less than or equal to 5 cm is called small hepatocellular carcinoma. Early stage of liver cancer lacks typical clinical manifestations. Once pain in the liver area, mass in the right upper abdomen, emaciation, jaundice, loss of appetite and other manifestations appear, it suggests that the disease may have entered the middle or late stage, and the prognosis of early stage liver cancer is better.
For liver cancer patients, the preferred and most effective treatment for liver cancer is still hepatectomy, and the overall 5-year survival rate after hepatectomy for liver cancer is about 30%, and the prognosis of small liver cancers that can be operated at early stage is better, and the survival rate reaches about 70%.